Clinical Trial Update: The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravitreal aflibercept for improving retinal nonperfusion in diabetic retinopathy has completed. The update provides efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Asan Medical Center | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED